HUE047739T2 - Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben - Google Patents

Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben

Info

Publication number
HUE047739T2
HUE047739T2 HUE13733697A HUE13733697A HUE047739T2 HU E047739 T2 HUE047739 T2 HU E047739T2 HU E13733697 A HUE13733697 A HU E13733697A HU E13733697 A HUE13733697 A HU E13733697A HU E047739 T2 HUE047739 T2 HU E047739T2
Authority
HU
Hungary
Prior art keywords
altered
lung cancer
peripheral blood
detecting rnas
rnas
Prior art date
Application number
HUE13733697A
Other languages
English (en)
Inventor
Scott Morris
David Mallery
Original Assignee
Viomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viomics Inc filed Critical Viomics Inc
Publication of HUE047739T2 publication Critical patent/HUE047739T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HUE13733697A 2012-01-06 2013-01-04 Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben HUE047739T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261584097P 2012-01-06 2012-01-06

Publications (1)

Publication Number Publication Date
HUE047739T2 true HUE047739T2 (hu) 2020-05-28

Family

ID=48745455

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13733697A HUE047739T2 (hu) 2012-01-06 2013-01-04 Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben

Country Status (12)

Country Link
US (2) US9422592B2 (hu)
EP (1) EP2809810B1 (hu)
JP (2) JP2015503356A (hu)
AU (1) AU2013207385B2 (hu)
CA (1) CA2860338C (hu)
DK (1) DK2809810T3 (hu)
ES (1) ES2769795T3 (hu)
HU (1) HUE047739T2 (hu)
IL (1) IL233163B (hu)
PL (1) PL2809810T3 (hu)
PT (1) PT2809810T (hu)
WO (1) WO2013103889A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015153284A1 (en) 2014-03-31 2015-10-08 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
JP2017538404A (ja) * 2014-11-14 2017-12-28 リキッド ジェノミクス,インコーポレイティド 癌を診断及び/又は観察するための循環無細胞rnaの使用
CN108350485A (zh) 2015-10-30 2018-07-31 精密科学发展有限责任公司 血浆dna的多重扩增检测测定以及分离和检测
CA3062622A1 (en) * 2017-05-10 2018-11-15 Nantomics, Llc Circulating rna for detection, prediction, and monitoring of cancer
WO2018226971A1 (en) * 2017-06-07 2018-12-13 Cedars-Sinai Medical Center Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery
SG11202002711WA (en) 2017-10-12 2020-04-29 Nantomics Llc Cancer score for assessment and response prediction from biological fluids
US11702703B2 (en) 2017-11-07 2023-07-18 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
CA3121923A1 (en) * 2018-12-18 2020-06-25 Wenying Pan Methods for detecting disease using analysis of rna
WO2020236939A2 (en) 2019-05-23 2020-11-26 Paradigm Diagnostics Tissue preparation using nuclease
EP4022093A4 (en) * 2019-08-27 2024-05-22 Exact Sciences Corporation CHARACTERIZATION OF METHYLATED DNA, RNA AND PROTEINS IN SUBJECTS SUSPECTED TO HAVE LUNG NEOPLASIA

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236506B1 (ko) 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
CA2218875C (en) 1991-07-23 2000-11-07 The Research Foundation Of State University Of New York Improvements in the in situ pcr
KR0171154B1 (ko) 1995-04-29 1999-03-20 배순훈 특징점 기반 움직임 추정을 이용하여 비디오 신호를 부호화하는 방법 및 장치
US6040139A (en) 1995-09-19 2000-03-21 Bova; G. Steven Laser cell purification system
US7785842B2 (en) 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US6329179B1 (en) 1996-03-26 2001-12-11 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
US6759217B2 (en) 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6100051A (en) 1997-06-27 2000-08-08 The United States Of America As Represented By The Department Of Health And Human Services Method utilizing convex geometry for laser capture microdissection
US8163524B2 (en) 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US7767422B2 (en) 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
US20040085443A1 (en) 2000-12-13 2004-05-06 Kallioniemi Olli P Method and system for processing regions of interest for objects comprising biological material
US7767390B2 (en) 2001-11-20 2010-08-03 Oncomedx, Inc. Methods for evaluating drug-resistance gene expression in the cancer patient
AU2003214072A1 (en) * 2002-03-07 2003-09-16 Bayer Aktiengesellschaft Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
CA2487427A1 (en) 2002-05-30 2003-12-11 Telogene Inc. Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
US7955846B2 (en) 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
WO2006031342A2 (en) 2004-08-19 2006-03-23 Applied Imaging Corp. Paraffin-control marker
EP2230316A1 (en) 2005-02-01 2010-09-22 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
US7405056B2 (en) 2005-03-02 2008-07-29 Edward Lam Tissue punch and tissue sample labeling methods and devices for microarray preparation, archiving and documentation
EP2468890B1 (en) 2006-01-05 2014-03-19 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers of the breast or lung
WO2008054828A2 (en) 2006-11-01 2008-05-08 The Ohio State University Research Foundation Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
US8189882B2 (en) 2008-01-30 2012-05-29 Clarient, Inc. Automated laser capture microdissection
US8880351B2 (en) 2008-03-25 2014-11-04 General Electric Company Method and apparatus for analysis of tissue microarrays
CN107254538A (zh) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
US8765383B2 (en) 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
WO2010123124A1 (ja) * 2009-04-24 2010-10-28 国立大学法人九州大学 固形がんの再発および予後因子、およびその臨床利用

Also Published As

Publication number Publication date
US9422592B2 (en) 2016-08-23
EP2809810A4 (en) 2015-12-02
AU2013207385A1 (en) 2014-07-10
ES2769795T3 (es) 2020-06-29
US20130196332A1 (en) 2013-08-01
PT2809810T (pt) 2020-02-14
PL2809810T3 (pl) 2020-07-27
JP2015503356A (ja) 2015-02-02
IL233163B (en) 2019-02-28
EP2809810A1 (en) 2014-12-10
AU2013207385B2 (en) 2018-09-13
CA2860338A1 (en) 2013-07-11
DK2809810T3 (da) 2020-02-03
WO2013103889A1 (en) 2013-07-11
CA2860338C (en) 2022-08-02
US20160333424A1 (en) 2016-11-17
EP2809810B1 (en) 2019-11-13
IL233163A0 (en) 2014-07-31
JP2019162102A (ja) 2019-09-26

Similar Documents

Publication Publication Date Title
HUE047739T2 (hu) Rendszer és eljárás tüdõrák által módosított RNS molekulák kimutatására perifériás vérben
EP2779907A4 (en) SYSTEM AND METHOD FOR MEDICAL MEASUREMENT
IL312551A (en) GRPR antagonists for the detection, diagnosis and treatment of GRPR-positive cancer
EP2695137A4 (en) SYSTEM AND METHOD FOR DISTRIBUTED MEDICAL DETECTION
EP2917734A4 (en) SYSTEM AND METHOD FOR DETECTION OF CANCER BASED ON SERUM
IL237486A0 (en) System and method for measuring lung capacity and endurance
PL2844146T3 (pl) Układ i sposób pomiaru uwagi
EP2887872A4 (en) Systems and methods for detecting carotenoid-related compounds in biological tissue
SG10201800720YA (en) Blood treatment systems and methods
EP2897526A4 (en) SYSTEM AND METHOD FOR DETERMINING THE SLEEPING STATE
EP2852813A4 (en) SYSTEM AND METHOD FOR DOSE MEASUREMENT
EP2883558A4 (en) BLOOD PURIFICATION DEVICE AND CORRESPONDING PRIMING METHOD
EP2695350A4 (en) MEDICAL SCANNING AND COMMUNICATION SYSTEM AND METHOD THEREFOR
EP2744579A4 (en) CONNECTED MULTIFUNCTIONAL SYSTEM AND METHOD OF USE
GB201120965D0 (en) System and method for detection of analytes
HK1197309A1 (en) Distributed transaction processing system and methods
EP2869764C0 (en) SYSTEM AND METHOD FOR MEASURING BLOOD PARAMETERS
HK1204016A1 (en) Methods and kits for detecting subjects at risk of having cancer
HK1209834A1 (en) Substances detection system and method
EP2693953A4 (en) MULTIMODAL MEDICAL RECORDING SYSTEM AND METHOD
EP2936411A4 (en) METHOD, SYSTEM AND DEVICE FOR SALES TRANSACTIONS
EP2674911A4 (en) SYSTEM FOR THE DETECTION OF DIFFERENT REGIONS AND METHOD FOR THE DETECTION OF DIFFERENT REGIONS
GB201115543D0 (en) Transaction system and method
EP2799910A4 (en) DOSE RATE MEASURING SYSTEM AND DOSING RATE MEASURING METHOD
EP2836267A4 (en) TREATMENT SYSTEM AND METHOD FOR PATHOLOGICAL ELECTROMAGNETIC LESIONS